HOME Study (Health Outcomes and Measures of the Environment Study)
Information source: National Institute of Environmental Health Sciences (NIEHS)
Information obtained from ClinicalTrials.gov on June 20, 2008 Link to the current ClinicalTrials.gov record.
Condition(s) targeted: Environmental Exposures; Environmental Monitoring; Child Development; Disorders of Environmental Origin
Intervention: Lead Hazard Control Intervention (Procedure); Injury Hazard Control Intervention (Procedure)
Phase: N/A
Status: Completed
Sponsored by: National Institute of Environmental Health Sciences (NIEHS) Official(s) and/or principal investigator(s): Bruce P Lanphear, MD, MPH, Principal Investigator, Affiliation: Children's Hospital Medical Center, Cincinnati
Summary
The goal of the HOME Study is to quantify the impact of low-level fetal and early childhood
exposures to environmental toxicants (lead, mercury, pesticides, polychlorinated biphenyls
[PCBs], environmental tobacco smoke, and alcohol) on child development (cognition, behavior,
growth, and hearing). The HOME Study will also evaluate meconium as a biomarker for fetal
exposure and test the effectiveness of home repairs to control lead hazards and injuries in
early childhood.
Clinical Details
Official title: Neurobehavioral Effects of Prevalent Neurotoxicants in Children: A Cohort Study of the Cincinnati Center for Children's Environmental Health
Study design: Prevention, Randomized, Single Blind, Active Control, Parallel Assignment, Safety/Efficacy Study
Primary outcome: Blood lead concentrationChild development/behavioral problems Intelligence quotient (IQ) scores Hearing Residential injuries
Detailed description:
Objectives/Hypotheses: Epidemiologic and experimental data have established the adverse
effects of numerous environmental toxicants, including lead, alcohol, mercury, PCB’s and
environmental tobacco smoke (ETS), on children’s brain function. In utero exposure to these
toxicants has been linked with cognitive deficits and behavioral problems. Lead exposure has
been linked to specific behavioral problems, including conduct disorder and delinquency, and
exposure to lead and ETS have been linked with mental retardation and attention deficit
hyperactivity disorder (ADHD)-like features. Still, many studies linking environmental
toxicants with neurobehavioral effect have only examined children with high exposures; there
is emerging evidence that adverse effects of exposure to lead, mercury, and PCBâs occur at
levels previously thought to be low. There are also data linking exposures to pesticides with
adverse neurobehavioral effects, but the data are too sparse to draw any conclusions.
The ideal biomarkers for measuring in utero exposure to specific toxicants have not been
established. Fetal exposure is typically measured with surveys, maternal blood, urine or
hair. Meconium - a chronic measure of in utero exposure - has only been validated as a
measure of cocaine and ETS exposure, but it offers numerous advantages, including a
non-invasive method to simultaneously test for exposure to numerous toxicants. Still, it is
unclear, whether conventional biomarkers or meconium is more predictive of the adverse
effects associated with specific toxicants. For lead exposure, emerging data indicate that
the investigators should emphasize primary prevention, but the safety and efficacy of lead
hazard controls are uncertain, especially for children with lower blood lead concentrations.
The investigators are testing the following hypotheses:
- In utero exposures measured by survey (alcohol and ETS), maternal and cord blood (lead
and mercury) maternal and cord serum (ETS), and urine (pesticides) are less predictive
of in utero effects of prevalent toxicants, including cognition, behavior problems,
growth and hearing, compared with the same toxicants in meconium.
- Prenatal and postnatal exposures to prevalent pesticides and ETS are associated with
adverse neurobehavioral effects, growth delay and hearing loss in children.
- Children in the Lead Hazard Reduction Group will have blood lead concentrations that are
2. 7 mcg/dL (30%) or lower at 36 months of age, significantly higher cognitive scores,
less hearing loss, greater growth velocity, and fewer behavioral problems and
developmental disorders, compared with those in the Control Group.
Approach: The investigators are conducting a longitudinal cohort study to examine the
dose-response of low-level exposures (pre- and postnatal) to prevalent neurotoxins with
neurobehavioral outcomes and specific development conditions, including conduct disorder and
behaviors consistent with ADHD. They will also conduct a nested, randomized controlled trial
to test the efficacy of lead hazard controls on blood lead concentrations and developmental
conditions and the efficacy of injury hazard controls on injury incidence and severity.
Expected Results: This trial would be the first to attempt to validate meconium as a measure
of exposure to numerous neurotoxicants and to test the efficacy of a residential lead and
injury hazard control on blood lead concentration, neurobehavioral functioning, and injury
incidence and severity.
Eligibility
Minimum age: 18 Years.
Maximum age: N/A.
Gender(s): Female.
Criteria:
Inclusion Criteria:
- Pregnancy
- Participating prenatal practice/clinic
- Participating hospital
Exclusion Criteria:
- Residence outside study area
- Plans to move outside study area within 1 year
- Home built after 1978
- Less than 18 years of age
- Beyond 19 weeks of gestation
- Diagnosis of diabetes
- Diagnosis of seizure disorder (taking anti-seizure medication)
- Diagnosis of thyroid disorder
- Diagnosis of AIDS or positive HIV test
- Diagnosis of bipolar disorder
- Diagnosis of schizophrenia
- Diagnosis of cancer resulting in radiation treatment or chemotherapy
Locations and Contacts
Cincinnati Children's Environmental Health Center, Cincinnati, Ohio 45229, United States
Additional Information
Related publications: Canfield RL, Henderson CR Jr, Cory-Slechta DA, Cox C, Jusko TA, Lanphear BP. Intellectual impairment in children with blood lead concentrations below 10 microg per deciliter. N Engl J Med. 2003 Apr 17;348(16):1517-26. Phelan KJ, Khoury J, Kalkwarf H, Lanphear B. Residential injuries in U.S. children and adolescents. Public Health Rep. 2005 Jan-Feb;120(1):63-70. Lanphear BP, Hornung R, Khoury J, Yolton K, Baghurst P, Bellinger DC, Canfield RL, Dietrich KN, Bornschein R, Greene T, Rothenberg SJ, Needleman HL, Schnaas L, Wasserman G, Graziano J, Roberts R. Low-level environmental lead exposure and children's intellectual function: an international pooled analysis. Environ Health Perspect. 2005 Jul;113(7):894-9. Nagaraja J, Menkedick J, Phelan KJ, Ashley P, Zhang X, Lanphear BP. Deaths from residential injuries in US children and adolescents, 1985-1997. Pediatrics. 2005 Aug;116(2):454-61.
Starting date: March 2003
Last updated: March 22, 2006
|